Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 12
Phase 21

Trial Status

Recruiting1
Terminated1

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT05523947Phase 1/2Recruiting
Clinical Trial of YH32367 in Patients With HER2 Positive Locally Advanced or Metastatic Solid Tumor
HER2-Positive Solid Tumor
PrincipalinvestigatorStart date: 2022-08-26
NCT04737122Phase 1Terminated
Study of LM-061 in Subjects in Advanced Tumors
Advanced Tumours
PrincipalinvestigatorStart date: 2021-05-06

Research Network

Collaboration Network

20 collaborators·50 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Southern Oncology Clinical Research Unit

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Jane Robertson, BSc, MBCHB, MD

AstraZeneca

Related
12 trials

Shared therapeutic areas:

Advanced Tumours
Similarity Score15%

Brian A Van Tine, M.D., Ph.D.

Washington University School of Medicine

Related
4 trials

Shared therapeutic areas:

HER2-positive Solid Tumor
Similarity Score15%

Bella Kaufman, MD

Chaim Sheba Medical Centre, Tel Hashomer, Israel

Related
1 trials

Shared therapeutic areas:

Advanced Tumours
Similarity Score15%

Thatcher Heumman

Vanderbilt-Ingram Cancer Center

Related
1 trials

Shared therapeutic areas:

HER2-positive Solid Tumor

Worked with same sponsors:

Yuhan Corporation
Collaborated on 1 trial
Similarity Score14%

Jennifer Man

Blacktown Hospital

Related
1 trials

Shared therapeutic areas:

HER2-positive Solid Tumor

Worked with same sponsors:

Yuhan Corporation
Collaborated on 1 trial
Similarity Score14%

Seok Yun Kang

Ajou University School of Medicine

Related
1 trials

Shared therapeutic areas:

HER2-positive Solid Tumor

Worked with same sponsors:

Yuhan Corporation
Collaborated on 1 trial
Similarity Score14%

Vinod Ganju

Peninsula & South Eastern Hematology and Oncology group

Related
1 trials

Shared therapeutic areas:

Advanced Tumours

Worked with same sponsors:

LaNova Medicines Limited
Collaborated on 1 trial
Similarity Score14%

Ju Won Kim

Korea University Anam Hospital

Related
1 trials

Shared therapeutic areas:

HER2-positive Solid Tumor

Worked with same sponsors:

Yuhan Corporation
Collaborated on 1 trial
Similarity Score14%

Gary Richardson

Cabrini Health

Related
1 trials

Shared therapeutic areas:

Advanced Tumours

Worked with same sponsors:

LaNova Medicines Limited
Collaborated on 1 trial
Similarity Score14%

Hyung Soon Park

Catholic University of Korea St. Vincent's Hospital

Related
1 trials

Shared therapeutic areas:

HER2-positive Solid Tumor

Worked with same sponsors:

Yuhan Corporation
Collaborated on 1 trial
Similarity Score14%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT05523947Phase 1/2PrincipalInvestigator

Clinical Trial of YH32367 in Patients With HER2 Positive Locally Advanced or Metastatic Solid Tumor

HER2-Positive Solid Tumor
Recruiting
NCT04737122Phase 1PrincipalInvestigator

Study of LM-061 in Subjects in Advanced Tumors

Advanced Tumours
Terminated

All 2 trials loaded